BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.
BCL-xL 作为西妥昔单抗耐药性结直肠癌的治疗靶点。
期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08434-5
Asmanidou Stella, Thiel Julia, Ekstrom Thomas L, Schueler Julia, Oswald Eva, Metzger Patrick, Blaumeiser Andreas C, Boerries Melanie, Wiebl Lisa-Marie, Schiffler Ronja, Tamas Raluca, Essmann Frank, Dong Meng, Johnsen Steven A, Kontermann Roland E, Olayioye Monilola A